HEYMAN RICHARD A. sold 4.9% of their position (1.23K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $32.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/22/2026ACC: 0001584759-26-000007
Director
Since Feb 2026
-1.23K
Net shares
Net seller
$32.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.23K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−512.00
Price / share
$26.46
Trade value
$13.55K
% of position
2.0%
1/20/2026
25.11K→24.59K
Common Stock
Indirect
Shares
−718.00
Price / share
$26.96
Trade value
$19.35K
% of position
2.9%
1/20/2026
24.59K→23.88K
Total
Net shares
−1.23K
Net value
-$32.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/20/2026 | S · Sale | −512.00 | $26.46 | $13.55K | 2.0% | 25.11K | 24.59K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −718.00 | $26.96 | $19.35K | 2.9% | 24.59K | 23.88K |
| Total | −1.23K | -$32.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned25.55K
Common Stock
DirectShares owned123.67K
Total
123.67K direct·25.55K indirect149.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.55K | Indirect |
| Common Stock | 123.67K | Direct |
| Total | 149.22K | 123.67K direct·25.55K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported